Pragati Raw Pharma Private Limited

Pragati Raw Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U52311MH1999PTC120384 Incorporated 17 June 1999 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹89.58 Cr
▼ 35% YoY
Net loss · FY 2025
₹25.55 Lakh
Net margin -0.3%
EBITDA · FY 2025
₹41.74 Lakh
EBITDA margin 0.5%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15.05 Lakh
Issued & subscribed
Open charges
₹26.38 Cr
Satisfied ₹1 Cr
Company age
27 yrs
Est. 1999
Directors on board
3
As per MCA filings

About Pragati Raw Pharma Private Limited

Data last updated:

Pragati Raw Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 June 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52311MH1999PTC120384. Its GSTIN is 27AABCP3959K1ZZ (Maharashtra). The company holds 6 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15.05 Lakh. It is led by directors including Saumil Hemal Mehta and Hemal Bhupatrai Mehta.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 404 – 405 Simran Plaza Corner Of Khar 3rd And 4th Road Khar West, Mumbai, Maharashtra, India – 400052.

As per the financials filed for FY 2025, the company reported a revenue of ₹89.58 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹25.55 Lakh (net margin -0.3%) and EBITDA of ₹41.74 Lakh (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.

As per MCA filings, the company has open charges of ₹26.38 Cr and satisfied charges of ₹1 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹14 Lakh; the latest was in March 2019.

Pragati Raw Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0010625). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pragatirawpharma.com.

Company details

CIN U52311MH1999PTC120384
Registration Number 120384
Incorporation Date 17 June 1999
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0010625
Key People
Saumil Hemal Mehta Director Hemal Bhupatrai Mehta Director Mohil Hemal Mehta Director

Recognitions & Rankings of Pragati Raw Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-18-0010625

Contact details

Pragati Raw Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is pragatirawpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    pragatirawpharma.com
  • Registered Address
    404 – 405 Simran Plaza Corner Of Khar 3rd And 4th Road Khar West, Mumbai, Maharashtra, India – 400052
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Pragati Raw Pharma Private Limited, buy the company report.

Comprehensive company report
Pragati Raw Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pragati Raw Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pragati Raw Pharma Private Limited, buy the company report.

Financials of Pragati Raw Pharma Private Limited

FY 2024 filings available

Pragati Raw Pharma Private Limited reported revenue of ₹89.58 Cr (down 35% YoY) for FY 2025.

Revenue · FY 2025
₹89.58 Cr ▼ 35%
Net loss · FY 2025
₹25.55 Lakh margin -0.3%
EBITDA · FY 2025
₹41.74 Lakh margin 0.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 13%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 78%
3 years · compounded
▼ 44%
5 years · compounded
▼ 5%

Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹41.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹25.55 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.5%
Net Profit Margin-0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pragati Raw Pharma Private Limited, buy the company report.

Board of directors of Pragati Raw Pharma Private Limited

Pragati Raw Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saumil Hemal Mehta
Also directs: Aquila Pharmaceutical LLP, Aquila Hospitality LLP
Director20 Jun 20179 Years 4 MonthsCurrent
Hemal Bhupatrai Mehta
Also directs: Aacharya Padmasagar Suri Foundation
Director17 Jun 199927 Years 4 MonthsCurrent
Mohil Hemal MehtaDirector05 Dec 20196 Years 11 MonthsCurrent
View all directors

Auditor

Pragati Raw Pharma Private Limited is audited by J. H. & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
J. H. & Co.FY 2024115320W

Shareholding

The shareholding of Pragati Raw Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pragati Raw Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹26.38 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹26.38 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Apr 2018100236253Hdfc Bank Limited₹7.75 CrOpen
15 Jul 201110304972Hdfc Bank Limited₹4.13 CrOpen
06 Apr 201010214900Hdfc Bank Limited₹4.5 CrOpen
22 Nov 200610030253Hdfc Bank Limited₹10 CrOpen
26 Jun 200390144550Corporation Bank₹1 CrSatisfied

To see the full charge records of Pragati Raw Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Pragati Raw Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹14 Lakh; the latest was in March 2019.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹14 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Hemal Mehta Huf, Bhupatrai Mehta Huf, 2 individuals
Aug 2006Funding round₹14 LakhInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pragati Raw Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Pragati Raw Pharma has 6 GST registrations: 2 active and 4 cancelled or inactive.

Total GSTINs
6
Active
2
Cancelled / inactive
4
GSTINStateStatusRegistered on
27AABCP3959K1ZZMaharashtraActive01 Jul 2017
24AABCP3959K1Z5GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Pragati Raw Pharma Private Limited, buy the company report.

Recent activity

Pragati Raw Pharma Private Limited has 8 board changes on record since 1999: 3 appointments and 5 cessations. The latest: Mohil Hemal Mehta ceased to be Additional Director on 30 Sep 2022.

AGM
Pragati Raw Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pragati Raw Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 1,000.00 Lakh registered on 22 Nov 2006 with Charge ID 10030253 was modified on 02 Aug 2023.
Ceased
Mohil Hemal Mehta ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 775.00 Lakh registered on 26 Apr 2018 with Charge ID 100236253 was modified on 18 Jun 2022.
Appointed
Mohil Hemal Mehta was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 775.00 Lakh with Charge ID 100236253 was registered on 26 Apr 2018.
Ceased
Saumil Hemal Mehta ceased to be Additional Director.
Ceased
Kiran Chandrakant Sanghavi ceased to be Additional Director.
Appointed
Saumil Hemal Mehta was appointed as Director.
Ceased
Rahul Jitendra Parekh ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 413.00 Lakh with Charge ID 10304972 was registered on 15 Jul 2011.

7 earlier events are in the company report.

Frequently asked questions

Pragati Raw Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 June 1999 (27+ years old) and is registered under CIN U52311MH1999PTC120384.

Pragati Raw Pharma has 3 current directors:

The latest financial statements of Pragati Raw Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Pragati Raw Pharma is 27AABCP3959K1ZZ, registered in Maharashtra. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 24AABCP3959K1Z5 (Gujarat).

The CIN (Corporate Identification Number) of Pragati Raw Pharma is U52311MH1999PTC120384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pragati Raw Pharma has 3 court cases on record: 3 filed by the company.

Pragati Raw Pharma was incorporated on 17 June 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.

Pragati Raw Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹14 Lakh; the latest was in March 2019.

Mohil Hemal Mehta ceased to be Additional Director on 30 Sep 2022. Mohil Hemal Mehta was appointed as Director on 05 Dec 2019. Saumil Hemal Mehta ceased to be Additional Director on 30 Sep 2017. Pragati Raw Pharma has 8 board changes on record in total.

Yes, Pragati Raw Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0010625).